Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Douglas A. McIntyre | Jul 26, 2020 at 8:04 AM EDT

Where Did Heart Disease and Cancer Go as COVID-19 Spread?

The focus of medical discussions in America has largely turned to the causes, symptoms, deaths, and cures for COVID-19. Lost…

Chris Lange | Jul 26, 2020 at 6:31 AM EDT

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players…

Douglas A. McIntyre | Jul 25, 2020 at 8:27 AM EDT

Could US COVID-19 Deaths Top 2,000 a Day?

A growing number of scientists believe that the increase in daily deaths due to COVID-19 in America is not over.

Chris Lange | Jul 24, 2020 at 11:25 AM EDT

Moderna’s Pain Is Arbutus’s Gain in COVID-19 Patent Ruling

Arbutus Biopharma stock has seen an incredible rise over the past few days after the firm won a patent dispute…

Chris Lange | Jul 24, 2020 at 10:51 AM EDT

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

Goldman Sachs has seven biopharma stocks on its Conviction Buy list, and these are not all coronavirus plays. The firm…

Chris Lange | Jul 22, 2020 at 10:04 AM EDT

Pfizer and BioNTech Set to Receive a Sweet Payoff for COVID-19 Vaccines

Pfizer and BioNTech S.E. aim to begin delivering 300 million doses of their vaccine for COVID-19 in 2021, but in…

Paul Ausick | Jul 22, 2020 at 8:37 AM EDT

7 Post-Coronavirus Health Care Stocks That Will Win in the Years Ahead

The current focus on controlling the COVID-19 pandemic, companies that provide other health care products and services have received less…

Jon C. Ogg | Jul 21, 2020 at 12:10 PM EDT

Owens & Minor Just Set Its Future Way Beyond COVID-19

There are no assurances that this stock will keep rising after such a rapid rise, but many investors with a…

Chris Lange | Jul 21, 2020 at 11:23 AM EDT

BioNTech Raises Over $400 Million to Boost COVID-19 Efforts

BioNTech is one of the leading companies in the race to a COVID-19 vaccine. With its shares up more than…

Chris Lange | Jul 21, 2020 at 10:56 AM EDT

Late-Stage Diabetes Study Sets the Stage for Lexicon Pharma

Lexicon Pharmaceuticals shares surged on Tuesday after the company announced positive topline data for its late-stage studies in type 2…

Chris Lange | Jul 21, 2020 at 10:09 AM EDT

Moleculin Biotech’s Antimetabolites COVID-19 on Track for Treatment Status

Moleculin Biotech joins the ever-expanding list of coronavirus stocks as the company announced that a second round of independent laboratory…

Chris Lange | Jul 21, 2020 at 8:51 AM EDT

Why Immuron’s New COVID-19 Study Is a Game Changer

Immuron continued its winning streak on Tuesday after the company announced that its IMM-124E has demonstrated neutralizing activity against the…

Douglas A. McIntyre | Jul 21, 2020 at 6:15 AM EDT

Peru and Chile Take Brunt of COVID-19 Spread

While the United States considers its COVID-19 spread with horror, two much smaller nations have suffered tremendously as well.

Chris Lange | Jul 20, 2020 at 2:51 PM EDT

Why This FDA Clearance Is a Big Deal For Sorrento Therapeutics

Sorrento Therapeutics has announced that its treatment for COVID-19 had cleared its Phase 2 study in hospitalized patients with moderate…

Chris Lange | Jul 20, 2020 at 10:21 AM EDT

GlaxoSmithKline Joins the Race for a COVID-19 Vaccine

GlaxoSmithKline has announced that it is acquiring a 10% stake in the German biopharma firm CureVac.

1 … 47 48 49 50 51 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Where Did Heart Disease and Cancer Go as COVID-19 Spread?

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Could US COVID-19 Deaths Top 2,000 a Day?

Moderna’s Pain Is Arbutus’s Gain in COVID-19 Patent Ruling

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

Pfizer and BioNTech Set to Receive a Sweet Payoff for COVID-19 Vaccines

7 Post-Coronavirus Health Care Stocks That Will Win in the Years Ahead

Owens & Minor Just Set Its Future Way Beyond COVID-19

BioNTech Raises Over $400 Million to Boost COVID-19 Efforts

Late-Stage Diabetes Study Sets the Stage for Lexicon Pharma

Moleculin Biotech’s Antimetabolites COVID-19 on Track for Treatment Status

Why Immuron’s New COVID-19 Study Is a Game Changer

Peru and Chile Take Brunt of COVID-19 Spread

Why This FDA Clearance Is a Big Deal For Sorrento Therapeutics

GlaxoSmithKline Joins the Race for a COVID-19 Vaccine

What JEPQ Actually Paid the Last Time the Nasdaq Fell 10%: a Stress Test for Its 10% Yield

VOO Is About to Become the First $1 Trillion ETF, and SPY Holders Are Paying 3x More for the Same Index

Laid Off at 58 With a 401(k) Loan, She Thought She Had 60 Days to Replace the Money. The Tax Code May Give Her Much Longer.

Laid Off at 58 With a 401(k) Loan, She Thought She Had 60 Days to Replace the Money. The Tax Code May Give Her Much Longer.

IRMAA Surprise: How Your 401(k) Distribution Today Triggers Medicare Surcharges Two Years Later

What JEPQ Actually Paid the Last Time the Nasdaq Fell 10%: a Stress Test for Its 10% Yield

VOO Is About to Become the First $1 Trillion ETF, and SPY Holders Are Paying 3x More for the Same Index

Health and Healthcare Articles

All Health and Healthcare Articles

Where Did Heart Disease and Cancer Go as COVID-19 Spread?

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Could US COVID-19 Deaths Top 2,000 a Day?

Moderna’s Pain Is Arbutus’s Gain in COVID-19 Patent Ruling

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

Pfizer and BioNTech Set to Receive a Sweet Payoff for COVID-19 Vaccines

7 Post-Coronavirus Health Care Stocks That Will Win in the Years Ahead

Owens & Minor Just Set Its Future Way Beyond COVID-19

BioNTech Raises Over $400 Million to Boost COVID-19 Efforts

Late-Stage Diabetes Study Sets the Stage for Lexicon Pharma

Moleculin Biotech’s Antimetabolites COVID-19 on Track for Treatment Status

Why Immuron’s New COVID-19 Study Is a Game Changer

Peru and Chile Take Brunt of COVID-19 Spread

Why This FDA Clearance Is a Big Deal For Sorrento Therapeutics

GlaxoSmithKline Joins the Race for a COVID-19 Vaccine

What JEPQ Actually Paid the Last Time the Nasdaq Fell 10%: a Stress Test for Its 10% Yield

VOO Is About to Become the First $1 Trillion ETF, and SPY Holders Are Paying 3x More for the Same Index

Laid Off at 58 With a 401(k) Loan, She Thought She Had 60 Days to Replace the Money. The Tax Code May Give Her Much Longer.

Featured Reads

Laid Off at 58 With a 401(k) Loan, She Thought She Had 60 Days to Replace the Money. The Tax Code May Give Her Much Longer.

IRMAA Surprise: How Your 401(k) Distribution Today Triggers Medicare Surcharges Two Years Later